Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4167071
Max Phase: Preclinical
Molecular Formula: C76H106N20O18S2
Molecular Weight: 1651.94
Molecule Type: Unknown
Associated Items:
ID: ALA4167071
Max Phase: Preclinical
Molecular Formula: C76H106N20O18S2
Molecular Weight: 1651.94
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(-c3ccccc3)cc2)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N2
Standard InChI: InChI=1S/C76H106N20O18S2/c1-4-41(2)60-70(110)91-53-39-115-116-40-54(90-63(103)47(20-11-29-81-75(77)78)84-58(99)37-83-62(102)49(36-59(100)101)86-68(108)55-22-13-31-94(55)72(112)50(88-66(53)106)34-43-16-7-5-8-17-43)67(107)93-61(42(3)98)71(111)85-48(21-12-30-82-76(79)80)64(104)89-52(38-97)65(105)87-51(35-44-25-27-46(28-26-44)45-18-9-6-10-19-45)73(113)96-33-15-24-57(96)74(114)95-32-14-23-56(95)69(109)92-60/h5-10,16-19,25-28,41-42,47-57,60-61,97-98H,4,11-15,20-24,29-40H2,1-3H3,(H,83,102)(H,84,99)(H,85,111)(H,86,108)(H,87,105)(H,88,106)(H,89,104)(H,90,103)(H,91,110)(H,92,109)(H,93,107)(H,100,101)(H4,77,78,81)(H4,79,80,82)/t41-,42+,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,60-,61-/m0/s1
Standard InChI Key: GNKMNASYNTZEBV-HLVNXAMPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1651.94 | Molecular Weight (Monoisotopic): 1650.7435 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. de Veer SJ, Li CY, Swedberg JE, Schroeder CI, Craik DJ.. (2018) Engineering potent mesotrypsin inhibitors based on the plant-derived cyclic peptide, sunflower trypsin inhibitor-1., 155 [PMID:29936356] [10.1016/j.ejmech.2018.06.029] |
Source(1):